C

Curis
D

CRIS

3.65000
USD
-0.38
(-9.43%)
مغلق
حجم التداول
0
الربح لكل سهم
-21
العائد الربحي
-
P/E
-0
حجم السوق
7,113,609
أصول ذات صلة المقالات
المزيد

العنوان: Curis Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.